CDEK
← All trials

NCT05057897

Phase 4Interventional

Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.

View on ClinicalTrials.gov ↗

Timeline

Start date
Dec 22, 2021
Primary completion
Sep 29, 2022
Completion date
Jul 28, 2023
First posted
Sep 27, 2021
Last posted
Sep 27, 2021
Enrollment
360
Arms / groups
1 / —
Source
AACT · ingestion pipeline

Sponsors

Drugs studied

Indications studied

CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.